echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 46 drug registration certificates including Lincomycin Hydrochloride Capsules were cancelled

    46 drug registration certificates including Lincomycin Hydrochloride Capsules were cancelled

    • Last Update: 2021-09-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network, September 1 News On August 27, the State Food and Drug Administration issued an announcement on the cancellation of registration certificates for 46 drugs including Lincomycin Hydrochloride Capsules (No.
    104 of 2021)
    .
     
    The original text is as follows:
     
     Announcement of theState Food and Drug Administration on the cancellation of registration certificates of 46 drugs including Lincomycin Hydrochloride Capsules (No.
    104 of 2021)
     
    According to the "Regulations for the Implementation of the Drug Administration Law of the People's Republic of China" and the " Administrative Measures for Drug Registration ", the State Drug Administration has decided to cancel 46 drug registration certificates including Lincomycin Hydrochloride Capsules
    .
     
    Hereby announce
    .
     
    Attachment: Catalogue of Cancellation of Drug Registration Certificate
     
    State Food and Drug Administration
     
    August 25, 2021
      Medical Network, September 1 News On August 27, the State Food and Drug Administration issued an announcement on the cancellation of registration certificates for 46 drugs including Lincomycin Hydrochloride Capsules (No.
    104 of 2021)
    .
     
      The original text is as follows:
     
     Announcement of the  State Food and Drug Administration on the cancellation of registration certificates of 46 drugs including Lincomycin Hydrochloride Capsules (No.
    104 of 2021)
     
      According to the "Regulations for the Implementation of the Drug Administration Law of the People's Republic of China" and the " Administrative Measures for Drug Registration ", the State Drug Administration has decided to cancel 46 drug registration certificates including Lincomycin Hydrochloride Capsules
    .
     
      Hereby announce
    .
     
      Attachment: Catalogue of Cancellation of Drug Registration Certificate
     
      State Food and Drug Administration
     
      August 25, 2021
      Medical Network, September 1 News On August 27, the State Food and Drug Administration issued an announcement on the cancellation of registration certificates for 46 drugs including Lincomycin Hydrochloride Capsules (No.
    104 of 2021)
    .
     
      The original text is as follows:
     
     Announcement of the  State Food and Drug Administration on the cancellation of registration certificates of 46 drugs including Lincomycin Hydrochloride Capsules (No.
    104 of 2021)
     State Food and Drug Administration on the cancellation of 46 lincomycin hydrochloride capsules and other drugs announcement registration certificate (No.
    104 of 2021) Drugs Drugs
     
      According to the "Regulations for the Implementation of the Drug Administration Law of the People's Republic of China" and the " Administrative Measures for Drug Registration ", the State Drug Administration has decided to cancel 46 drug registration certificates including Lincomycin Hydrochloride Capsules
    .
    Drug Registration Drug Registration Drug Registration
     
      Hereby announce
    .
     
      Attachment: Catalogue of Cancellation of Drug Registration Certificate
     
      State Food and Drug Administration
     
      August 25, 2021
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.